Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (alveolar cells type 1) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 17 Parkinson's papers of 3,508 | 0.62 |
| pathways Reactome | 11 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 12501
Sealed predictions
- WNT3A in dopamine neurons, braak-0.21 (p 0.589) → -0.43 (p 0.243)receipt 12509
Swarm cases
receipt 12509: WNT3A in dopamine neurons, braak
- power
- full sample -0.34 (p 0.170, n 18), 95% CI -0.70 to +0.15. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.32 (p 0.191, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.38 (p 0.118, n 18). could be the mix.
- skeptic
- leave-one-out range -0.50 to -0.26, sign flips 0; without severely affected donors -0.34 (p 0.170, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for WNT3A in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts